BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37036707)

  • 1. Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America.
    Khalili M; Leonard KR; Ghany MG; Hassan M; Roberts LR; Sterling RK; Belle SH; Lok AS;
    JAMA Netw Open; 2023 Apr; 6(4):e237018. PubMed ID: 37036707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
    Brahmania M; Lombardero M; Hansen BE; Terrault NA; Lok AS; Perrillo RP; Belle SH; Di Bisceglie AM; Feld JJ; Lee WM; Fried MW; Janssen HLA;
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2541-2551.e2. PubMed ID: 30743006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
    Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
    Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.
    Zhou K; Wahed AS; Cooper S; Di Bisceglie AM; Fontana RJ; Ghany MG; Khalili M; Lok AS; Perrillo R; Lee WM; Lau DTY; Sterling R; Janssen HLA; Terrault NA
    Am J Gastroenterol; 2019 Nov; 114(11):1753-1763. PubMed ID: 31658127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
    Bzowej NH; Tran TT; Li R; Belle SH; Smith CI; Khalili M; Chung R; Tsai N; Terrault N;
    Am J Gastroenterol; 2019 Aug; 114(8):1283-1291. PubMed ID: 31082876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America.
    Sterling RK; King WC; Khalili M; Chung RT; Sulkowski M; Jain MK; Lisker-Melman M; Ghany MG; Wong DK; Hinerman AS; Bhan AK; Wahed AS; Kleiner DE;
    Hepatology; 2021 Sep; 74(3):1174-1189. PubMed ID: 33743541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
    Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B.
    Bzowej N; Han S; Degertekin B; Keeffe EB; Emre S; Brown R; Reddy R; Lok AS;
    Liver Transpl; 2009 Sep; 15(9):1010-20. PubMed ID: 19718627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.
    Lok AS; Ganova-Raeva L; Cloonan Y; Punkova L; Lin HS; Lee WM; Ghany MG;
    J Viral Hepat; 2017 Nov; 24(11):1032-1042. PubMed ID: 28581155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.
    Ghany MG; Perrillo R; Li R; Belle SH; Janssen HL; Terrault NA; Shuhart MC; Lau DT; Kim WR; Fried MW; Sterling RK; Di Bisceglie AM; Han SH; Ganova-Raeva LM; Chang KM; Lok AS; ;
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):183-92. PubMed ID: 25010003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America.
    Cooper SL; King WC; Mogul DB; Ghany MG; Schwarz KB;
    J Viral Hepat; 2021 Jul; 28(7):1042-1056. PubMed ID: 33893706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
    Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
    World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study.
    Wang T; Smith DA; Campbell C; Mokaya J; Freeman O; Salih H; McNaughton AL; Cripps S; Várnai KA; Noble T; Woods K; Collier J; Jeffery K; Davies J; Barnes E; Matthews PC
    BMC Infect Dis; 2021 Jun; 21(1):610. PubMed ID: 34174833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
    Mantzoukis K; Rodríguez-Perálvarez M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011645. PubMed ID: 28321877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes.
    Lau DTY; Ganova-Raeva L; Wang J; Mogul D; Chung RT; Lisker-Melman M; Chang KM; Shaikh OS; Janssen HLA; Wahed AS; Lok AS;
    Hepatology; 2021 May; 73(5):1637-1651. PubMed ID: 32860463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study.
    Ramírez Mena A; Thiam M; Ka D; Niang I; Tine J; Fortes L; Ndiaye K; Ndiaye O; Fall M; Gaye A; Ngom NF; Fall F; Berzigotti A; Kirk GD; Jaquet A; Seydi M; Wandeler G;
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):539-549. PubMed ID: 38588691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.
    Chung W; Jiang SF; Paksarian D; Nikolaidis A; Castellanos FX; Merikangas KR; Milham MP
    JAMA Netw Open; 2019 Nov; 2(11):e1914344. PubMed ID: 31675080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
    Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
    JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.